The Lancet Infectious Diseases in conversation with
En podcast af The Lancet Group
118 Episoder
-  Jan Felix Drexler and Fernando Bozza on Oropouche virusUdgivet: 14.4.2025
-  Prasad Kulkarni on dengue monoclonal antibodiesUdgivet: 23.2.2024
-  Oriol Mitjà on treatment of early syphilis in adultsUdgivet: 8.1.2024
-  Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in MozambiqueUdgivet: 10.11.2023
-  Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infectionsUdgivet: 27.9.2022
-  Richard Maude on malaria chemoprophylaxis in CambodiaUdgivet: 27.9.2022
-  Ben Cowling on COVID-19 vaccines in Hong KongUdgivet: 15.7.2022
-  Hugh Adler on monkeypox in the UKUdgivet: 26.5.2022
-  Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICsUdgivet: 14.12.2021
-  Laura Cooper and Sam Okiror on polio eradication in AfricaUdgivet: 12.10.2021
-  Paul Chapman on a hookworm vaccineUdgivet: 19.8.2021
-  Josep Llibre on preventing SARS-CoV-2 transmission at concertsUdgivet: 27.5.2021
-  Yap Boum on COVID-19 testing in low resource settingsUdgivet: 25.3.2021
-  Antimalarial resistance in southeast AsiaUdgivet: 25.7.2019
-  Trial in phage therapy for burn infectionsUdgivet: 4.10.2018
-  Pandemic influenza: 100 yearsUdgivet: 21.6.2018
-  Bedaquiline and delamanid combination for drug-resistant TB: The Lancet Infectious Diseases: February 13, 2018Udgivet: 14.2.2018
-  MERS and transchromosomic cows: The Lancet Infectious Diseases: January 10, 2018Udgivet: 10.1.2018
-  PrEP in the UK: The Lancet Infectious Diseases: October 17, 2017Udgivet: 18.10.2017
-  Polio in Afghanistan: The Lancet Infectious Diseases: August 14, 2017Udgivet: 14.8.2017
Saleha Hassan, Senior Editor at The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from polio eradication in Africa to COVID-19 vaccines in Hong Kong, the treatment of early syphilis in adults to Mpox in the UK, and more.
 
 